ENTvantage Dx Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
4
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
14
ENTvantage Dx General Information
Description
Manufacturer of in-office diagnostic test kits intended to determine the cause of ear, nose, and throat illnesses. The company's product qualitatively identifies the major bacterial sinusitis pathogens and provides differentiation from viral sinusitis infections, enabling physicians to prescribe antibiotic treatment for patients who have bacterial sinusitis, and reducing the unnecessary prescription of antibiotics.
Contact Information
Website
www.entvantagedx.comCorporate Office
- 4200 Marathon Boulevard
- Suite 200
- Austin, TX 78756
- United States
Corporate Office
- 4200 Marathon Boulevard
- Suite 200
- Austin, TX 78756
- United States
ENTvantage Dx Timeline
ENTvantage Dx Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
11. Accelerator/Incubator | 13-Feb-2023 | Completed | Generating Revenue | |||
10. Later Stage VC | 20-Jan-2021 | Completed | Generating Revenue | |||
9. Grant | 01-Feb-2020 | Completed | Generating Revenue | |||
8. Later Stage VC | 20-Aug-2019 | Completed | Generating Revenue | |||
7. Later Stage VC | 01-Oct-2018 | Completed | Generating Revenue | |||
6. Early Stage VC (Series B) | 03-Nov-2017 | Completed | Generating Revenue | |||
5. Early Stage VC (Series A) | 01-Oct-2016 | Completed | Generating Revenue | |||
4. Grant | 14-Jan-2016 | Completed | Generating Revenue | |||
3. Accelerator/Incubator | 10-Dec-2014 | Completed | Generating Revenue | |||
2. Grant | 02-Apr-2014 | $1K | Completed | Generating Revenue |
ENTvantage Dx Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A |
ENTvantage Dx Comparisons
Industry
Financing
Details
ENTvantage Dx Competitors (2)
One of ENTvantage Dx’s 2 competitors is Q-linea, a Formerly VC-backed company based in Uppsala, Sweden.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Q-linea | Formerly VC-backed | Uppsala, Sweden | ||||
Neurent Medical | Venture Capital-Backed | Braintree, MA |
ENTvantage Dx Patents
ENTvantage Dx Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2018244352-A1 | Devices and methods for diagnosis of sinusitis | Inactive | 28-Mar-2017 | ||
JP-2020515365-A | Sinusitis diagnostic device and method | Pending | 28-Mar-2017 | ||
EP-3600066-A1 | Devices and methods for diagnosis of sinusitis | Inactive | 28-Mar-2017 | ||
EP-3600066-A4 | Devices and methods for diagnosis of sinusitis | Inactive | 28-Mar-2017 | ||
CA-3057853-A1 | Devices and methods for diagnosis of sinusitis | Pending | 28-Mar-2017 | A61B10/0045 |
ENTvantage Dx Signals
ENTvantage Dx Investors (14)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
HSC Next | Accelerator/Incubator | |||
Capital Factory | Accelerator/Incubator | Minority | ||
Denniston Family Office | Family Office | Minority | ||
Sea Purity Investments | Family Office | Minority | ||
National Institutes of Health | Government |
ENTvantage Dx FAQs
-
When was ENTvantage Dx founded?
ENTvantage Dx was founded in 2013.
-
Where is ENTvantage Dx headquartered?
ENTvantage Dx is headquartered in Austin, TX.
-
What is the size of ENTvantage Dx?
ENTvantage Dx has 4 total employees.
-
What industry is ENTvantage Dx in?
ENTvantage Dx’s primary industry is Diagnostic Equipment.
-
Is ENTvantage Dx a private or public company?
ENTvantage Dx is a Private company.
-
What is ENTvantage Dx’s current revenue?
The current revenue for ENTvantage Dx is
. -
How much funding has ENTvantage Dx raised over time?
ENTvantage Dx has raised $6.63M.
-
Who are ENTvantage Dx’s investors?
HSC Next, Capital Factory, Denniston Family Office, Sea Purity Investments, and National Institutes of Health are 5 of 14 investors who have invested in ENTvantage Dx.
-
Who are ENTvantage Dx’s competitors?
Q-linea and Neurent Medical are competitors of ENTvantage Dx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »